IGF-1 LR3

IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3) is a modified analogue of the naturally occurring growth factor IGF-1.
In research environments, the IGF-1 LR3 peptide is studied for its interaction with cellular growth signalling
pathways and receptor systems involved in protein synthesis, metabolic regulation and tissue development.

Within research peptide markets, IGF-1 LR3 is frequently examined in experimental models exploring
cellular proliferation, growth signalling pathways and metabolic activity. Structured product pages allow
researchers to review compound classification, biochemical mechanisms and laboratory research context
before selecting materials. You can browse the full
research peptides catalogue for related compounds.

Mechanism of Action

• IGF-1 receptor interaction: Activation of cellular growth signalling pathways
• PI3K/Akt pathway activity: Protein synthesis and metabolic signalling research
• MAPK pathway activation: Cellular proliferation and growth regulation studies
• Reduced IGF-binding protein interaction: Increased receptor availability in research models

Current Research Focus

• Cellular growth and proliferation signalling research
• Muscle cell development and protein synthesis models
• Glucose metabolism and metabolic signalling studies
• IGF-1 receptor pathway investigation

IGF-1 LR3 Research Context

IGF-1 LR3 research continues to develop within experimental environments where investigators are
studying growth factor signalling pathways and cellular regulation mechanisms. Structural modifications
to the peptide reduce interaction with IGF-binding proteins, allowing researchers to investigate
receptor-level activity in controlled models.

This page presents investigational context in a structured format suitable for research-focused audiences.
It avoids medical claims or usage guidance and instead summarises compound classification, signalling
pathways and areas of laboratory investigation.

Key Notes